Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity
- PMID: 7494860
- DOI: 10.1016/0163-7258(95)00012-6
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity
Abstract
Severe and prolonged impairment of mitochondrial beta-oxidation leads to microvesicular steatosis, and, in severe forms, to liver failure, coma and death. Impairment of mitochondrial beta-oxidation may be either genetic or acquired, and different causes may add their effects to inhibit beta-oxidation severely and trigger the syndrome. Drugs and some endogenous compounds can sequester coenzyme A and/or inhibit mitochondrial beta-oxidation enzymes (aspirin, valproic acid, tetracyclines, several 2-arylpropionate anti-inflammatory drugs, amineptine and tianeptine); they may inhibit both mitochondrial beta-oxidation and oxidative phosphorylation (endogenous bile acids, amiodarone, perhexiline and diethylaminoethoxyhexestrol), or they may impair mitochondrial DNA transcription (interferon-alpha), or decrease mitochondrial DNA replication (dideoxynucleoside analogues), while other compounds (ethanol, female sex hormones) act through a combination of different mechanisms. Any investigational molecule should be screened for such effects.
Similar articles
-
Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines.J Hepatol. 1997;26 Suppl 2:43-53. doi: 10.1016/s0168-8278(97)80496-5. J Hepatol. 1997. PMID: 9204409 Review.
-
Central role of mitochondria in drug-induced liver injury.Drug Metab Rev. 2012 Feb;44(1):34-87. doi: 10.3109/03602532.2011.604086. Epub 2011 Sep 6. Drug Metab Rev. 2012. PMID: 21892896 Review.
-
Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.J Pharmacol Exp Ther. 1988 Nov;247(2):745-50. J Pharmacol Exp Ther. 1988. PMID: 3183967
-
Hepatotoxicity due to mitochondrial dysfunction.Cell Biol Toxicol. 1999;15(6):367-73. doi: 10.1023/a:1007649815992. Cell Biol Toxicol. 1999. PMID: 10811531 Review.
-
Mitochondrial involvement in drug-induced liver injury.Handb Exp Pharmacol. 2010;(196):311-65. doi: 10.1007/978-3-642-00663-0_11. Handb Exp Pharmacol. 2010. PMID: 20020267 Review.
Cited by
-
Primary non-alcoholic fatty liver disease in hypertensive patients.Australas Med J. 2013 Jun 30;6(6):325-30. doi: 10.4066/AMJ.2013.1648. Print 2013. Australas Med J. 2013. PMID: 23837080 Free PMC article.
-
Developmental bisphenol A (BPA) exposure leads to sex-specific modification of hepatic gene expression and epigenome at birth that may exacerbate high-fat diet-induced hepatic steatosis.Toxicol Appl Pharmacol. 2015 Apr 15;284(2):101-12. doi: 10.1016/j.taap.2015.02.021. Epub 2015 Mar 5. Toxicol Appl Pharmacol. 2015. PMID: 25748669 Free PMC article.
-
Cellular Bioenergetics: Experimental Evidence for Alcohol-induced Adaptations.Function (Oxf). 2022 Aug 24;3(5):zqac039. doi: 10.1093/function/zqac039. eCollection 2022. Function (Oxf). 2022. PMID: 36120487 Free PMC article. Review.
-
Role of mitochondrial depolarization and disrupted mitochondrial homeostasis in non-alcoholic steatohepatitis and fibrosis in mice.Int J Physiol Pathophysiol Pharmacol. 2019 Oct 15;11(5):190-204. eCollection 2019. Int J Physiol Pathophysiol Pharmacol. 2019. PMID: 31777643 Free PMC article.
-
Mitochondria as the _target of Hepatotoxicity and Drug-Induced Liver Injury: Molecular Mechanisms and Detection Methods.Int J Mol Sci. 2022 Mar 18;23(6):3315. doi: 10.3390/ijms23063315. Int J Mol Sci. 2022. PMID: 35328737 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
